News - Townsend Investments
LATEST NEWS:
ARCHIVE - 2013

Formulation work commences for inhaled forms of Lynovex®:  NovaBiotics Ltd, the Aberdeen-based clinical-stage biotechnology company (“NovaBiotics” or the “Company”)...

Read More

The categories the company have been shortlisted in are for the Life Science Business Leadership (2013) and Community Engagement.

Congratulating the nominees, Julia Brown, director of life ...

Read More

The Business Desk:  MULTI-channel retailer High Street TV (HSTV) has secured an exclusive deal with Alliance Healthcare to sell America's bestselling anti-blemish skin care range into 16,000 p...

Read More

NovaBiotics Ltd, the clinical-stage biotechnology company, today announced that it has partnered with the Cystic Fibrosis Trust and Health Sciences Scotland, for a Phase1/2a clinical trial of its n...

Read More

Townsend Investments has made a donation to DEBRA, the national charity that supports individuals and families affected by Epidermolysis Bullosa (EB).


Read More

The Business Desk: THRIVING Yorkshire business High Street TV is smashing through its targets as it looks set to achieve a record 70% increase in growth.
 
The Harrogate-based retail...

Read More

The CEO and CSO, Dr. Deborah O’Neil, will be presenting on the Company and its lead product, Lynovex®, at 11.40am on 15 October 2013. 

NovaBiotics is developing novel pep...

Read More

Harrogate Advertiser: Direct response television multi-channel retailer High Street TV (HSTV) has entered into an exclusive strategic partnership with live shopping channel Ideal Wo...

Read More

Licensing and co-development agreement for anti-fungal peptide treatment, Novexatin®
Aberdeen, UK

NovaBiotics Ltd, the Aberdeen-based clinical-stage biotechnology company (“...

Read More

Financial Times: Andrew Malcher is bringing a new kind of US-style infomercial to British Screens, writes Andrew Bounds


Read More

Combining NovaBiotics novel anti-infective peptides & Luminaderm polymers with Malvern's bespoke Lipodisq® delivery system, this exciting partnership has already generated stand-out preclin...

Read More

One of the UK’s biggest NHS Trusts, Leeds Teaching Hospitals Trust is expanding its use of competence verification system Reset Certification Scheme with the installation of a...

Read More

NovaBiotics and the cystic fibrosis (CF) teams at Aberdeen Royal Infirmary are investigating the microbiological and mucolytic potential of Lynovex, NovaBiotics’ drug candidate which is being...

Read More